# Nephros Inc: filings

NEPH · Nasdaq · CIK 1196298 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/neph.md) · [Financials](/companies/neph/financials.md) · [Filings](/companies/neph/filings.md) · [Insiders](/companies/neph/insiders.md)

## Reports and events: 315 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 223, 8-K 172, 424B3 73, 10-Q 53, EFFECT 31, SC 13D/A 23, POS AM 21, UPLOAD 19, 10-K 18, 3 16, CORRESP 15, S-1/A 15, DEF 14A 14, SC 13G 13, S-1 12, DEFA14A 11, D/A 9, D 7, S-8 7, 4/A 6, SC 13G/A 4, 10-K/A 3, ARS 3, RW 3, S-3 3, SC TO-C 3, 424B5 2, 8-K/A 2, AW 2, CT ORDER 2, NT 10-K 2, PRE 14A 2, PRER14A 2, SC 13D 2, SCHEDULE 13G 2, 25-NSE 1, 8-A12B 1, CERT 1, DEF 14C 1, NT 10-Q 1, PRE 14C 1, S-3/A 1, SCHEDULE 13D/A 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:01 ET | [DEF 14A](/filings/0001493152-26-047012.md) | Proxy statement, period 2026-10-14 | 0001493152-26-047012 |
| 2026-10-13 | 20:01 ET | [8-K](/filings/0001493152-26-046814.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046814 |
| 2026-09-16 | 21:16 ET | [SCHEDULE 13D/A](/filings/0001398344-26-017130.md) | Ownership report, active investor, amended | 0001398344-26-017130 |
| 2026-08-10 | 20:00 ET | [10-Q](/filings/0001493152-26-036851.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036851 |
| 2026-08-06 | 20:02 ET | [8-K](/filings/0001493152-26-036331.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036331 |
| 2026-06-15 | 21:43 ET | [8-K](/filings/0001493152-26-028539.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028539 |
| 2026-05-07 | 20:36 ET | [8-K](/filings/0001493152-26-021734.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-021734 |
| 2026-05-07 | 20:00 ET | [10-Q](/filings/0001493152-26-021701.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021701 |
| 2026-04-30 | 20:05 ET | [10-K/A](/filings/0001493152-26-020416.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-020416 |
| 2026-03-27 | 20:00 ET | [8-K](/filings/0001493152-26-013189.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013189 |
| 2026-03-12 | 20:01 ET | [10-K](/filings/0001493152-26-009848.md) | Annual report, period 2025-12-31 | 0001493152-26-009848 |
| 2025-11-26 | 21:15 ET | [8-K](/filings/0001493152-25-025155.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001493152-25-025155 |
| 2025-11-06 | 21:01 ET | [10-Q](/filings/0001493152-25-021061.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021061 |
| 2025-08-11 | 20:15 ET | [8-K](/filings/0001641172-25-022978.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022978 |
| 2025-08-07 | 20:39 ET | [10-Q](/filings/0001641172-25-022596.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022596 |
| 2025-06-16 | 20:15 ET | [8-K](/filings/0001641172-25-015250.md) | 5.07 Shareholder vote results | 0001641172-25-015250 |
| 2025-05-15 | 20:00 ET | [10-Q](/filings/0001641172-25-010836.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010836 |
| 2025-05-08 | 20:15 ET | [8-K](/filings/0001641172-25-009262.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009262 |
| 2025-04-30 | 20:15 ET | [DEF 14A](/filings/0001641172-25-007775.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007775 |
| 2025-04-28 | 20:15 ET | [8-K](/filings/0001641172-25-006427.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-006427 |
| 2025-04-01 | 01:24 ET | [8-K](/filings/0001641172-25-001940.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-001940 |
| 2025-03-24 | 15:13 ET | [10-K](/filings/0001641172-25-000234.md) | Annual report, period 2024-12-31 | 0001641172-25-000234 |
| 2025-03-06 | 21:15 ET | [8-K](/filings/0001493152-25-009390.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009390 |
| 2025-03-04 | 21:05 ET | [8-K](/filings/0001493152-25-009035.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-009035 |
| 2024-11-14 | 21:03 ET | [10-Q](/filings/0001493152-24-045793.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045793 |
| 2024-11-13 | 21:15 ET | [8-K](/filings/0001493152-24-045135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045135 |
| 2024-08-26 | 20:05 ET | [8-K](/filings/0001493152-24-033872.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-033872 |
| 2024-08-08 | 20:00 ET | [10-Q](/filings/0001493152-24-030745.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030745 |
| 2024-05-24 | 20:05 ET | [8-K](/filings/0001493152-24-021342.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-021342 |
| 2024-05-09 | 20:40 ET | [10-Q](/filings/0001493152-24-018483.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018483 |
| 2024-05-09 | 20:15 ET | [8-K](/filings/0001493152-24-018435.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-018435 |
| 2024-05-01 | 12:00 ET | [8-K](/filings/0001493152-24-017355.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-017355 |
| 2024-04-12 | 20:01 ET | [DEF 14A](/filings/0001493152-24-014442.md) | Proxy statement, period 2024-04-12 | 0001493152-24-014442 |
| 2024-03-15 | 20:25 ET | [10-K](/filings/0001493152-24-010107.md) | Annual report, period 2023-12-31 | 0001493152-24-010107 |
| 2024-03-07 | 21:15 ET | [8-K](/filings/0001493152-24-009216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-009216 |
| 2023-11-08 | 21:00 ET | [10-Q](/filings/0001493152-23-039890.md) | Quarterly report, period 2023-09-30 | 0001493152-23-039890 |
| 2023-11-06 | 21:05 ET | [8-K](/filings/0001493152-23-039516.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-039516 |
| 2023-08-09 | 20:15 ET | [8-K](/filings/0001493152-23-027357.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-027357 |
| 2023-08-09 | 20:00 ET | [10-Q](/filings/0001493152-23-027337.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027337 |
| 2023-06-01 | 20:00 ET | [8-K](/filings/0001493152-23-019798.md) | 5.07 Shareholder vote results | 0001493152-23-019798 |
| 2023-05-11 | 20:00 ET | [8-K](/filings/0001493152-23-016374.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-016374 |
| 2023-05-10 | 20:07 ET | [10-Q](/filings/0001493152-23-016161.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016161 |
| 2023-04-21 | 20:01 ET | [DEF 14A](/filings/0001493152-23-013210.md) | Proxy statement, period 2023-04-21 | 0001493152-23-013210 |
| 2023-04-04 | 20:00 ET | [8-K](/filings/0001493152-23-010797.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-010797 |
| 2023-03-23 | 21:05 ET | [10-K](/filings/0001493152-23-008716.md) | Annual report, period 2022-12-31 | 0001493152-23-008716 |
| 2023-03-08 | 21:25 ET | [8-K](/filings/0001493152-23-007004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-007004 |
| 2023-02-03 | 12:00 ET | [8-K](/filings/0001493152-23-003465.md) | 5.02 Departure or appointment of officers or directors | 0001493152-23-003465 |
| 2023-01-11 | 13:57 ET | [8-K](/filings/0001493152-23-001134.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-001134 |
| 2022-11-21 | 21:01 ET | [8-K](/filings/0001493152-22-033098.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-22-033098 |
| 2022-11-15 | 21:27 ET | [10-Q](/filings/0001493152-22-032511.md) | Quarterly report, period 2022-09-30 | 0001493152-22-032511 |

Page 1 of 7. [Older](/companies/neph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.